ESMO Preceptorship on Prostate Cancer Lugano 2016

Oncology Meeting Resources

11 Nov - 12 Nov, Lugano, Switzerland

ESMO Preceptorship on Prostate Cancer

Main learning objectives for the ESMO Preceptorship on Prostate Cancer Lugano 2016 included learning about fundamentals of epidemiology, natural history and diagnosis as contributing factors to heterogeneity in prostate cancer; understanding essentials in the assessments and multidisciplinary treatment of prostate cancer and learning about advances in treatment and novel targets in prostate cancer.

Presentations from the Preceptorship are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links

Presenter Presentation title Session title
A. Petrachkov, RU Participants Clinical Case Discussion: 77 Year-Old Man With Regional Recurrence of Prostate Cancer Session 3 - Locally-Advanced Prostate Cancer
A. Horwich, UK First-Line Hormone Therapy for Metastatic Disease; Role and Toxicities Session 4 - Initial Systemic Therapy
E. Castro, ES First and Second-line Chemotherapy Session 4 - Initial Systemic Therapy
Y. Dakdouki, FR Participants Clinical Case Discussion: Metastatic Prostate Cancer Session 4 - Initial Systemic Therapy
C. Handforth, UK Participants Clinical Case Discussion: Decision Making in Older Patients with Prostate Cancer Session 4 - Initial Systemic Therapy
E. Kharchenko, RU Participants Clinical Case Discussion: 57 Cycles of Docetaxel for Metastatic Castration-Resistant Prostate Cancer Session 4 - Initial Systemic Therapy
W. Gerritsen, NL Next Generation Androgen Receptor Axis Inhibitors Session 5 - Castration Resistant Prostate Cancer (CRPC)
A. Horwich, UK Isotope Therapies and Palliative Radiotherapy Session 5 - Castration Resistant Prostate Cancer (CRPC)
H.-B. Fiebrich-Westra, NL Participants Clinical Case Discussion: A Heavily Pretreated Prostate Cancer: Emerging Treatments Session 5 - Castration Resistant Prostate Cancer (CRPC)
R. Matei, RO Participants Clinical Case Discussion: Long Time Maintained Complete Response After Combination Treatment for Metastatic Prostate Cancer Session 5 - Castration Resistant Prostate Cancer (CRPC)
W. Gerritsen, NL Bone Targeting (Bisphosphonates and RANK Ligands) Session 6 - Novel Therapies
W. Gerritsen, NL Immunotherapy and Other New Drug Targets Session 6 - Novel Therapies
C. Cattrini, IT Participants Clinical Case Discussion:A Case of Biochemical Response in a Young BRCA Positive Patient on Treatment With Olaparib Session 6 - Novel Therapies
N. Mitsimponas, DE Participants Clinical Case Discussion: An Interesting Case of Prostate Carcer With Bone Marrow Infiltration, Meningiosis Carcinomatosa and Liver Metastasis Session 6 - Novel Therapies